Glycos Biotechnologies, Inc. ("GlycosBio") is dedicated to the production of targeted bio-based chemicals for petrochemical producers and trading companies. Through collaborative partnerships - GlycosBio works with companies interested in expanding into the emerging biochemical value chain - leveraging our feedstock knowledge, advanced metabolic engineering techniques, micro-organism development, process development and chemical production capabilities at the Company's commercial facility - Bio-XCell Malaysia.
The Company’s portfolio of microorganisms produce a variety of high-value chemicals from carbon sources contained in a diverse set of feedstocks and co-products that are traditionally considered low value or underutilized.
GlycosBio has discovered and protected metabolic pathways and biological processes around an abundant diversified set of feedstocks, like glycerin embedded within thin stillage or condensed syrup, from the ethanol industry, co-product streams from the oleochemicals industry, such as gums, fatty acids and even crude extracts from animal and plant sources.
Our technology also works equally well with sugars and oil from algal sources; these diversified materials align well with our non-foodstuffs feedstock – microorganism development strategy.